FEBS Letters · 1995 · 61 citations · 22 references
Life SciencesMicrobiologyPharmacologyMolecular PharmacologyMycologyPlant-microbe InteractionsAntifungal AgentsAntifungal PharmacologyAntifungal ResistanceFungal BiochemistryFungal ImmunologyFungal PhysiologyAntifungal Drug ResistanceAntifungal Resistance MechanismsAzole ResistanceCytochrome P450 Enzyme ActivityDirect SelectionEnzyme-inhibitor BindingFungal Drug ResistanceFungal Enzyme Inhibitors
Azole antifungals inhibit CYP51A1-mediated sterol 14 alpha-demethylation and the mechanism(s) of resistance to such compounds in Ustilago maydis were examined. The inhibition of growth was correlated with the accumulation of the substrate, 24-methylene-24,25-dihydrolanosterol (eburicol), and depletion of ergosterol. Mutants overcoming the effect of azole antifungal treatment exhibited a unique phenotype with leaky CYP51A1 activity which was resistant to inhibition. The results demonstrate that alterations at the level of inhibitor binding to the target site can produce azole resistance. Similar changes may account for fungal azole resistance phenomena in agriculture, and also in medicine where resistance has become a problem in immunocompromised patients suffering from AIDS.
22
Characterization of an azole-resistant Candida glabrata isolate
H. Vanden Bossche, Patrick Marichal, Frank C. Odds et al. · Antimicrobial Agents and Chemotherapy · 1992 · 203 citations · Full text
Primary Structure of the P450 Lanosterol Demethylase Gene from <i>Saccharomyces cerevisiae</i>
Vernon F. Kalb, Connie W. Woods, Thomas G. Turi et al. · DNA · 1987 · 177 citations
Azole resistance in Candida albicans.
J Ryley, Robert Wilson, Keith Barrett‐Bee · PubMed · 1984 · 176 citations
Nystatin-Resistant Mutants of Yeast: Alterations in Sterol Content
Robin A. Woods · Journal of Bacteriology · 1971 · 134 citations · Full text